Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) EPS (Weighted Average and Diluted) (2021 - 2022)

Catheter Precision (VTAK) has disclosed EPS (Weighted Average and Diluted) for 2 consecutive years, with $2.02 as the latest value for Q4 2022.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 103.27% to $2.02 in Q4 2022 year-over-year; TTM through Dec 2022 was -$25.98, a 75.73% increase, with the full-year FY2022 number at -$25.98, up 89.53% from a year prior.
  • EPS (Weighted Average and Diluted) was $2.02 for Q4 2022 at Catheter Precision, up from -$7130.2 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $24062.5 in Q3 2021 to a low of -$7130.2 in Q3 2022.